Ms. Ana Belen Oton MD
Hematologist-Oncologist | Hematology & Oncology
700 Delaware St Davis Pavilion, Mc 4 Denver CO, 80204About
Dr. Ana Oton is a hematologist oncologist practicing in Denver, CO. Dr. Oton specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Education and Training
Facultad Medica De Caracas 1998
Central University Of Venezuela, Luis Razetti School Of Medicine Medicine
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM- Medical Oncology
Internal MedicineAmerican Board of Internal MedicineABIM- 2004
Internal MedicineAmerican Board of Internal MedicineABIM- Hematology- 2007
Provider Details
Expert Publications
Data provided by the National Library of Medicine- New strategies to overcome limitations of reversible EGFR tyrosine kinase inhibitor therapy in non-small cell lung cancer.
- MAGE A3 antigen-specific cancer immunotherapeutic.
- Anaplastic lymphoma kinase gene rearrangements in non-small cell lung cancer are associated with prolonged progression-free survival on pemetrexed.
- Oncogene status predicts patterns of metastatic spread in treatment-naive nonsmall cell lung cancer.
- Rapid-onset hypogonadism secondary to crizotinib use in men with metastatic nonsmall cell lung cancer.
- Symptomatic reduction in free testosterone levels secondary to crizotinib use in male cancer patients.
- Cancer clinical research in Latin America: current situation and opportunities. Expert opinion from the first ESMO workshop on clinical trials, Lima, 2015.
- PS01.72: Payer and Patient Out-of-Pocket Costs: A Projection of the Financial Burden of Non-Small Cell Lung Cancer Care in the United States Through 2040: Topic: Medical Oncology.
- Safety Analyses of Pemetrexed-cisplatin and Pemetrexed Maintenance Therapies in Patients With Advanced Non-squamous NSCLC: Retrospective Analyses From 2 Phase III Studies.
- Factors Associated with Adherence to and Treatment Duration of Erlotinib Among Patients with Non-Small Cell Lung Cancer.
- Current and projected patient and insurer costs for the care of patients with non-small cell lung cancer in the United States through 2040.
- Real-World Treatment Sequences and Outcomes Among Patients With Non-Small Cell Lung Cancer (RESOUNDS) in the United States: Study Protocol.
Awards
- 2006 ECOG, Young Investigator Award
- 6th Annual ECOG Symposium, Ft. Lauderdale, Florida for the research p Young Investigator Award
- 2009 Denver Health, Denver Health Star Award
Treatments
- Lung Cancer
Professional Memberships
- Member ASCO
- Member SWOG
- Member ASH
- Member IASLC
Fellowships
- University of Pittsburgh Medical Center 2007
- University of Pittsburgh Medical Center, Internal Medicine - Hematology and Oncology 2007
Experience & Accolades
- Assistant Professor2007School of Medicine, Medicine
Ms. Ana Belen Oton MD's Practice location
Ms. Ana Belen Oton MD's reviews
Write ReviewPatient Experience with Dr. Oton
Recommended Articles
- Potential Causes of Leukopenia
IntroductionA decrease in the number of white blood cells (WBCs) is referred to as leukopenia. There are several causes for leukopenia. It may be due to certain drugs, cancer, radiation and chemotherapy for cancer, stem cell transplant, surgery, steroids, or autoimmune disorders. The immune system...
- How Dogs Are Helping with Lymphoma Research
According to the Cornell Chronicle (CC), Cornell and Tufts University have received a huge grant for the study of human lymphoma, using a humane approach to test on dogs.The dogs in the study will already have lymphoma and it’s hoped they’ll be cured in the process of this research study.There...
- The Lymphoma Research Foundation Announces Partnership with the Annals of Lymphoma
The Lymphoma Research Foundation (LRF) is the nation’s largest non-profit organization for lymphoma research, and they just announced their partnership with the Annals of Lymphoma (AOL). This was all revealed in September during Blood Cancer Awareness Month. LRF is devoted to exclusively funding...
- Study Finds 3% of Pediatric Non-Hodgkin Lymphoma Cases Are Transplant Recipients
Lymphoma is a blood cancer that affects both children and adults.Lymphoma begins its growth in the lymphatic white blood cells of the lymph system. This system is a major warrior in fighting off infections and diseases. It is part of the body’s immunity team.The lymph system loops throughout the...
- 'Robocop' Stem Cells Developed to Fight Cancer
Cancer is the second-leading cause of death in the United States, although due to several advancements in cancer screening and treatment, survival rates have begun to improve.A new cancer therapyResearchers at the University of Minnesota and Mayo Clinic have developed a new type of cancer therapy...
- Superheroes Unite For Elementary Student Fighting Lymphoma
Anyone diagnosed with cancer knows how terrifying and debilitating the news can be. Now just imagine how horrible an experience it would be for an elementary school student to hear that they have cancer.It is a sad fact that thousands of children are diagnosed with cancer every year, and it is...
Nearby Providers
- Dr. Devchand Paul PHD DO4700 Hale Pkwy Denver CO 80220
- Dr. Muhammad Siddique MBBS7750 S BROADWAY LITTLETON CO 80122
- Dr. SARA ROBINSON M.D.University Of Colorado Denver CO 80262
- Dr. Tomer Mark MD, MSC12605 E 16TH AVE AURORA CO 80045
- Dr. Peter Kabos MD1665 Aurora Ct Aurora CO 80045
- Dr. Elaine Lam MD12605 E 16th Ave Aurora CO 80045